Recent Editions of IMPAQ Health News
Learn about racial and ethnic health disparities, COVID-19 vaccines and treatments, the expansion of telehealth, and original COVID-19 coverage from IMPAQ experts, including a publicly available dashboard for exploring the latest updates in the vast COVID-19 clinical trials landscape.
Learn about racial and ethnic health disparities, the impact of COVID-19 on the ACA, and other rules, reports, and insights, including a blog post by IMPAQ and AIR health experts on equity, access
This edition highlights reports on racial and ethnic health disparities and the impact of COVID-19 on the LGBTQ community, along with relevant rules and insights, including a blog post by IMPAQ Medicaid experts Tim Hill and Melissa Hafner on how the pandemic will create the perfect storm for the Medicaid system.
This edition of IMPAQ Health News highlights stories on the intersection of COVID-19 and movements for social justice, racial and ethnic disparities of the pandemic, and the growing mental health crisis.
Learn about the psychological toll of COVID-19, testing and contact tracing efforts, and possible effects on Medicaid providers and beneficiaries in this edition of IMPAQ Health News.
In this week’s edition, learn the latest on COVID-19 contact tracing efforts, the impact of the pandemic on mental health, and how the virus continues to hit marginalized communities the hardest.
This edition of IMPAQ Health News highlights stories on the racial and ethnic disparities of the pandemic, job and health insurance loss, and shifts in hospital operations due to COVID-19.
Read about the latest US response to COVID-19, new research demonstrating how the pandemic is disproportionally affecting communities of color, and an article from IMPAQ experts analyzing past senate responses to public health crises.
Read the latest updates on the US government response to the COVID-19 pandemic, including a $2.2 trillion stimulus package to stabilize the economy, as well as new guidance on social distancing through the end of April.
Learn about the US government response to the COVID-19 pandemic, including several CMS announcements regarding insurance and benefits, as well as a new IMPAQ study on whether coverage limitations on opioid alternatives increase opioid prescription rates.